Behandlingen skal fortsætte, hvis sygdommen er stabil, dvs. ved statisk, delvis eller komplet tumorrespons, forudsat at hunden tåler behandlingen tilstrækkelig godt.
Treatment should be maintained in the case of stable disease, i.e. static, partial or complete tumour response, provided that the product is sufficiently well tolerated.